UNSPSC 51172181: Stilonium iodide

This classification denotes an antispasmotic agent with the molecular formula C22H30NO.I, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 19B3530KQ6, chemically known as n,n,n-triethyl-n-(2-(4-styrylphenoxy)ethyl)ammonium iodide but more generally known as stilonium iodide, which bears US NIH Compound Identifier 6433339. European Medicines Agency schedules Stilonium iodide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10652MIG.

UNSPSC 51172181 Stilonium iodide is a Commodity code that does not reflect the actual work being solicited under it in recent state and local procurement. The three most recent opportunities tagged to this code involve offender drug testing services, direct-to-manufacturer prescription programs, and generic pharmaceutical distribution — none of which involve stilonium iodide or related chemical compounds. The Collin County Community Supervision and Corrections Department RFP seeks specimen collection and drug testing services, including immunoassay screening and LC/MS/MS or GC/MS confirmation, for approximately 25,031 annual tests across two North Texas sites. The Texas Health and Human Services Commission issued an RFI exploring direct-to-manufacturer pharmaceutical contracting models. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) is procuring generic multi-source pharmaceuticals and OTC products for state and local government facilities across multiple participating jurisdictions. None of these solicitations involve the chemical product the code nominally describes.

The code shows little relevant recent activity aligned to its stated commodity classification. Issuing bodies across the recent opportunities include a county criminal-justice department, a state health agency, and a multistate cooperative purchasing vehicle serving state and local facilities in Minnesota and Oregon. Geographic spread covers Texas (Collin County and state-level) and Minnesota-Oregon (through MMCAP). The mismatch between the code's chemical-product scope and the pharmaceutical-services and -distribution work actually being solicited suggests either tagging error in the underlying procurement records or a fundamental misalignment between the UNSPSC classification and the buying activity the code is meant to capture. State and local procurement professionals should verify the code's applicability before investing development effort.